Loading clinical trials...
Loading clinical trials...
This study is intended to report changes in the weight and metabolic indicators of the subjects six months after the end of the study for adults with a risk factor of 27 kg/m2 or higher (formerly the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gangnam Severance Hospital
NCT05981508 · Body Weight, Body Weight Changes, and more
NCT07026903 · Obesity and Overweight, the Study Will Focus on Weight Reduction Through Lifestyle Changes Aided by Insights From Continuous Glucose Monitoring
NCT04910620 · Weight Reduction
NCT02364128 · Morbid Obesity, Weight Reduction
NCT03534336 · Weight Reduction, Health Knowledge, Attitudes, Practice
Yongin Severance hospital
Yongin, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions